China’s Rise in Drug Development Looms Over U.S.
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
The regulation would have required all publicly traded companies to disclose whether they faced significant risks from climate change and its effects.
Many of the ships stranded in the Persian Gulf depend on coverage negotiated at Lloyd’s, the center of marine insurance for more than 300 years.
When newly public companies have been valued as richly as SpaceX, OpenAI and Anthropic seem likely to be, the outlook for ordinary investors has been poor.
Elon Musk and his bankers are working to create a self-fulfilling prophesy for SpaceX’s massive initial public offering: Make investors feel that the risks of passing up the stock outweigh those of buying into it.
U.S. companies skirted at least $40 billion in taxes since the beginning of 2025 thanks to schemes in places like Malta, Bermuda and Cyprus.
The superstar is part of group that has bought a basketball team in Italy, with a plan to move the club to Rome in hopes of making it part of a new league.
The artificial intelligence giant was just valued at $900 billion, surpassing OpenAI. Here are the numbers behind its rise — and headwinds it faces.
A stadium outside Boston that will host seven World Cup games is actually closer to Providence, R.I., prompting officials there to capitalize on that proximity to lure fans.
Oil prices and stock markets fluctuated as investors assessed tentative signs of a pact to extend a cease-fire.